The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Thrombosis and Coagulopathy in COVID-19
Open accessAbstract
Since December 2019, an outbreak of coronavirus disease 2019 (COVID-19) which initially occurred in the city of Wuhan, located in China's Hubei province, spread around the world and on March 11, 2020, the World Health Organization declared the new Coronavirus disease 2019 (COVID-19) as a pandemic. The presence of comorbidities (eg, cardiovascular disease, obesity), Sepsis Induced Coagulopathy score >4, elevation of D-dimer (>6 times the normal value), C-reactive protein, troponins and other disseminated intravascular coagulation markers; is associated to a worse prognosis in hospitalized patients with severe COVD-19, reaching a hospital mortality of 42%. Initial anticoagulant treatment with low molecular weight heparin has been shown to reduce mortality by 48% at 7 days and 37% at 28 days and achieve a significant improvement in the arterial oxygen pressure/inspired fraction of O2 (PaO2/FiO2) by mitigating the formation of microthrombi and associated pulmonary coagulopathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., Xiang, J., Wang, Y., Song, B., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30566-3 · Cited by 27,263
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
Klok, F. A., Kruip, M. J. H. A., van der Meer, N. J. M., Arbous, M. S., Gommers, D. A. M. P. J., Kant, K. M., Kaptein, F. H. J., van Paassen, J., Stals, M. A. M., Huisman, M. V., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.013 · Cited by 5,028
Tang, N., Bai, H., Chen, X., Gong, J., Li, D., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14817 · Cited by 3,559
CDC Weekly, C., & The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · China CDC Weekly · doi:10.46234/ccdcw2020.032 · Cited by 2,889
Bikdeli, B., Madhavan, M. V., Jimenez, D., Chuich, T., Dreyfus, I., Driggin, E., Nigoghossian, C. D., Ageno, W., Madjid, M., Guo, Y., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.04.031 · Cited by 2,885
COVID-19 and its implications for thrombosis and anticoagulation
Connors, J. M., & Levy, J. H. (2020) · Blood · doi:10.1182/blood.2020006000 · Cited by 2,369
Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State
Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020) · JAMA · doi:10.1001/jama.2020.4326 · Cited by 2,259
Lodigiani, C., Iapichino, G., Carenzo, L., Cecconi, M., Ferrazzi, P., Sebastian, T., Kucher, N., Studt, J.-D., Sacco, C., Bertuzzi, A., et al. (2020) · Thrombosis Research · doi:10.1016/j.thromres.2020.04.024 · Cited by 2,054
ISTH interim guidance on recognition and management of coagulopathy in COVID‐19
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14810 · Cited by 1,925
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Cui, S., Chen, S., Li, X., Liu, S., & Wang, F. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14830 · Cited by 1,806
Coagulation abnormalities and thrombosis in patients with COVID-19
Levi, M., Thachil, J., Iba, T., & Levy, J. H. (2020) · The Lancet Haematology · doi:10.1016/s2352-3026(20)30145-9 · Cited by 1,544
Incidence of venous thromboembolism in hospitalized patients with COVID‐19
Middeldorp, S., Coppens, M., van Haaps, T. F., Foppen, M., Vlaar, A. P., Müller, M. C. A., Bouman, C. C. S., Beenen, L. F. M., Kootte, R. S., Heijmans, J., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14888 · Cited by 1,447
D‐dimer levels on admission to predict in‐hospital mortality in patients with Covid‐19
Zhang, L., Yan, X., Fan, Q., Liu, H., Liu, X., Liu, Z., & Zhang, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14859 · Cited by 1,347
World Health Organization (2020) · Pediatria i Medycyna Rodzinna · doi:10.15557/pimr.2020.0003 · Cited by 1,329
The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team (2020) · PubMed Central · Cited by 1,278
Schünemann, H. J., Cushman, M., Burnett, A. E., Kahn, S. R., Beyer-Westendorf, J., Spencer, F. A., Rezende, S. M., Zakai, N. A., Bauer, K. A., Dentali, F., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022954 · Cited by 819
Spyropoulos, A. C., Levy, J. H., Ageno, W., Connors, J. M., Hunt, B. J., Iba, T., Levi, M., Samama, C. M., Thachil, J., Giannis, D., et al. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14929 · Cited by 657
Wang, J., Hajizadeh, N., Moore, E. E., McIntyre, R. C., Moore, P. K., Veress, L. A., Yaffe, M. B., Moore, H. B., & Barrett, C. D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14828 · Cited by 536
The versatile heparin in COVID-19
Thachil, J. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14821 · Cited by 404 · cited 3×
“Other nonanticoagulant actions of heparin include its antiviral role (experimental models), decreased collagen deposits and antiarrhythmic properties (animal models), as well as modulation of endothelial dysfunction, improvement of microvascular dysfunction, and mitigation of pulmonary coagulopathy.(26,27) In patients…”
BackgroundMarietta, M., Ageno, W., Artoni, A., Candia, E. D., Gresele, P., Marchetti, M., Marcucci, R., & Tripodi, A. (2020) · Blood transfusion · doi:10.2450/2020.0083-20 · Cited by 348
Anti-Inflammatory Effects of Heparin and Its Derivatives: A Systematic Review
Mousavi, S., Moradi, M., Khorshidahmad, T., & Motamedi, M. (2015) · Advances in Pharmacological Sciences · doi:10.1155/2015/507151 · Cited by 258
Chinese expert consensus on diagnosis and treatment of coagulation dysfunction in COVID-19
Song, J., Wang, G., Zhang, W., Zhang, Y., Li, W., & Zhou, Z. (2020) · Military Medical Research · doi:10.1186/s40779-020-00247-7 · Cited by 169
Vivas, D., Roldán, V., Esteve‐Pastor, M. A., Roldán, I., Tello‐Montoliu, A., Ruiz-Nodar, J. M., Cosín-Sales, J., Martínez, J. M. G., Consuegra, L., Ferreiro, J. L., et al. (2020) · Revista Española de Cardiología · doi:10.1016/j.recesp.2020.04.006 · Cited by 118
Vivas, D., Roldán, V., Esteve‐Pastor, M. A., Roldán, I., Tello‐Montoliu, A., Ruiz-Nodar, J. M., Cosín-Sales, J., Martínez, J. M. G., Consuegra, L., Ferreiro, J. L., et al. (2020) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2020.04.025 · Cited by 97
Coagulopathy associated with COVID-19
Lee, S. G., Fralick, M., & Sholzberg, M. (2020) · Canadian Medical Association Journal · doi:10.1503/cmaj.200685 · Cited by 77
COVID-19 and coagulative axis: review of emerging aspects in a novel disease
Boccia, M., Aronne, L., Celia, B., Mazzeo, G., Ceparano, M., D’Agnano, V., Parrella, R., Valente, T., Bianco, A., & Perrotta, F. (2020) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2020.1300 · Cited by 66
Anticoagulant and antiarrhythmic effects of heparin in the treatment of COVID‐19 patients
Rodrigues, F. S. M., Tavares, J. G. P., Pires-Oliveira, M., de Carvalho, R. G., Errante, P. R., Taha, M. O., Fagundes, D. J., & Caricati‐Neto, A. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14902 · Cited by 24
Cited by
Kell, D. B., Laubscher, G. J., & Pretorius, E. (2022) · Biochemical Journal · doi:10.1042/bcj20220016 · Cited by 271
Bucciarelli, V., Nasi, M., Bianco, F., Seferovic, J., Ivkovic, V., Gallina, S., & Mattioli, A. V. (2022) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2021.09.009 · Cited by 152
The neurobiology of SARS-CoV-2 infection
Meinhardt, J., Streit, S., Dittmayer, C., Manitius, R. V., Radbruch, H., & Heppner, F. L. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-023-00769-8 · Cited by 64
Metadata
- Authors
- Gómez-Mesa, J. E., Galindo-Coral, S., Montes, M. C., & Muñoz Martin, A. J.
- Venue
- Current Problems in Cardiology
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 46
- Issue
- 3
- Pages
- 100742
- ISSN
- 0146-2806 (ISSN-L)
- OpenAlex
- W3097903491
- Cited by
- 272
- References
- 28
- FWCI
- 6.55
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.